At 10.21x trailing earnings and 10.60x forward, HIG is the cheapest quality P&C carrier in the comp set alongside CNA at 10.33x, while WRB commands 16.58x and TRV 14.59x. A P/B of 2.05x against a peer median closer to 2.3-2.8x implies the market is not fully capitalizing HIG's near-TRV return profile, which may reflect its larger personal lines exposure and legacy asbestos reserves rather than franchise weakness. Investors should note the PEG of 0.45 looks optically cheap but is not meaningful for insurers, where book value accrual and reserve assumptions, not EPS growth rates, drive valuation.

The 14-point loss ratio swing with a stable expense ratio strongly suggests the 2025 improvement was not earned-pricing driven but reserve driven, consistent with the unusually low-50s loss ratios that a diversified P&C and workers' comp book rarely sustains on current accident-year economics alone. Underwriting margin compression from 19.3% in 2025Q4 to 8.7% in 2026Q2 therefore looks less like a discipline failure and more like normalization of prior-year development, though the persistence of social inflation and medical cost trends in general liability and workers' comp could push the ratio higher still. A 91.3% combined ratio remains profitable, but the trajectory, not the level, is what warrants monitoring.

ROA held at 1.5% in 2026Q3 while ROE climbed to 6.9%, a divergence consistent with both modest asset growth and a tightening equity base from buybacks, rather than a step-change in operational profitability. The 46.08% gross margin between earned premiums and incurred losses is structurally capped by loss-cost inflation, so the durability of the 23% ROE hinges on whether the higher-rate environment continues to lift net investment income on the float generated by HIG's $68.3B liability base. If reserve releases fade, investors should expect ROE to converge toward the mid-teens unless underwriting margins recover on an underlying basis.

Financial leverage is a non-issue at these levels—interest coverage of 12.58x in 2026Q2, despite moderation from 29.84x a year earlier, reflects a debt burden too small to materially affect solvency. The relevant leverage question for HIG is underwriting leverage, and with the assets-to-equity multiple compressing from 5.0x to 4.6x as equity grew 20.4% while liabilities grew 7.7%, the company appears to be de-risking its balance sheet faster than premium growth is deploying capital. If the reserve tailwind reverses and retained earnings slow, management may face a trade-off between the escalating $331M quarterly dividend and discretionary repurchases, a tension investors should monitor in coming quarters.

WRB trades at 3.03x book with a 19.5% ROE, while HIG earns a comparable trailing return at just 2.05x book—a gap that would normally signal a franchise discount, though it may be partially justified by HIG's heavier personal lines mix and legacy A&E exposure that TRV and CB do not carry to the same degree. Relative to MET at 12.8% ROE and 2.30x P/B, HIG looks superior on both axes, supporting the view that its Group Benefits segment diversifies earnings without imposing the valuation drag of a pure life insurer. The decelerating revenue trajectory to -0.2% YoY likely explains part of the multiple compression relative to WRB and TRV, both of which have sustained premium growth through the hard market.